Hostname: page-component-848d4c4894-p2v8j Total loading time: 0.001 Render date: 2024-06-02T22:07:14.624Z Has data issue: false hasContentIssue false

The Spectrum of Rapid Cycling

Published online by Cambridge University Press:  07 November 2014

Trisha Suppes*
Affiliation:
Dr. Suppes is associate professor of psychiatry in the Department of Psychiatry and director of the Bipolar Disorders Clinic and Research Program at UT Southwestern Medical Center in Dallas, Texas.

Extract

While rapid cycling was first identified by Dunner and Fieve in 1974, there is quite a good historical background on the concept. In the 1800s Falret and colleagues identified what they called a “circular course distinct from alternating.” What they meant by “alternating” was a period of remission following an episode. Currently, all types and ranges of cycling are lumped under one rubric; the spectrum ranges from having >4 cycling episodes, the minimum required for rapid cycling, through ultradian cycling, which is far more severe.

While some patients manifest chronic depression with periodic hypermania, which is known as bipolar II, others have ultradian cycles, which are often seen as pure affective instability. We do not know whether these types represent different stages of a disorder that exists on a spectrum or whether they are actually distinct categories of the disorder: one being patients who experience mania, depression, and then remission; the second being those with more continuous cycling that includes ultradian cycling. Greater understanding of the biological underpinnings of the illness will help to determine whether these conditions exist on a spectrum.

Rapid cycling may become less prevalent with age. In the Depression Collaborative Study, Coryell and colleagues found a diminishment of rapid cycling over the course of 13 years. Studies from the Stanley Bipolar Foundation group suggest that the cycling may accelerate in some, but not others. Over a long observation period in ~100 patients, Koukopoulos and colleagues found that once a pattern of rapid cycling is established in a patient, this pattern may become a hallmark of their illness.

Type
Research Article
Copyright
Copyright © Cambridge University Press 2004

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Dunner, DL, Fieve, RR. Clinical factors in lithium carbonate prophylaxis failure. Arch Gen Psychiatry 1974;30:229233.CrossRefGoogle ScholarPubMed
2.Falret, JP. Marche de lafolie (suite). Gaz Hop. 1851;24(1819).Google Scholar
3.Coryell, W, Soloman, D, Turvey, C, et al.The long-term course of rapid-cycling bipolar disorder. Arch Gen Psychiatry. 2003;60:914920.CrossRefGoogle ScholarPubMed
4.Suppes, T, Leverich, GS, Keck, PE Jr, et al.The Stanley Foundation bipolar outcome network II. Demographics and illness characteristics of the first 261 patients. J Affect Disord. 2001;67:4559.CrossRefGoogle ScholarPubMed
5.Koukopoulos, A, Sani, G, Koukopoulos, AE, et al.Duration and stability of the rapid-cycling course: a long-term personal follow-up of 109 patients. J Affect Disord. 2003;73:7585.CrossRefGoogle ScholarPubMed
6.Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.Google Scholar
7.Altshuler, LL, Suppes, T, Black, D, et al.Impact of antidepressant discontinuation after acute bipolar depression remission on rate of depressive relapse at 1-year follow-up. Am J Psychiatry. 2003;160:12521262.CrossRefGoogle Scholar
8.Ghaemi, S, El-Mallakh, R, Baldassano, CF, et al.Antidepressant treatment of bipolar I depression: long-term outcome. Poster presented at: Annual Meeting of the American College of Neuropsychopharmacology; December 2003; San Juan, Puerto Rico.Google Scholar
9.Ghaemi, SN, Hsu, DJ, Soldani, F, Goodwin, FK. Antidepressants in bipolar disorder: the case for caution. Bipolar Disord. 2003;5:421433.CrossRefGoogle ScholarPubMed
10.Post, RM, Leverich, GS, Nolen, WA, et al.A re-evaluation of the role of antidepressants in the treatment of bipolar depression: data from the Stanley Foundation Bipolar Network. Bipolar Disord. 2003;5:396406.CrossRefGoogle ScholarPubMed
11.Calabrese, JR, Shelton, MD, Rapport, DJ, et al.Is rapid cycling a predictor of non-response to lithium? Poster presented at: Annual Meeting of the American College of Neuropsychopharmacology; December 2002; San Juan, Puerto Rico.Google Scholar
12.Calabrese, JR, Suppes, T, Bowden, C, et al.A double blind, placebo-controlled, prophylaxis study of lamotrigine in a rapid-cycling bipolar disorder. J Clin Psychiatry. 2000;61:841850.CrossRefGoogle Scholar
13.Denicoff, KD, Smith-Jackson, EE, Disney, ER, et al.Comparative prophylactic efficacy of lithium, carbamazepine, and the combination in bipolar disorder. J Clin Psychiatry. 1997;11:470478.CrossRefGoogle Scholar
14.Suppes, T. Review of the use of topiramate for treatment of bipolar disordrers. J Clin Psychopharmacol. 2002;6:599609.CrossRefGoogle Scholar
15.Pies, R. Combining lithium and anticonvulsants in bipolar disorder: a review. Ann Clin Psychiatry. 2002;14:4.CrossRefGoogle ScholarPubMed
16.Calabrese, JR, Shelton, MD, Rapport, DJ, et al.Current research on rapid cycling bipolar disorder and its treatment. J Affect Disord. 2001;67:241255.CrossRefGoogle ScholarPubMed
17.Suppes, T, Webb, A, Paub, B, et al.Clinical outcomes in a randomized one-year trial of clozapine versus treatment as usual for patients with treatment-resistance illness and a history of mania. Am J Psychiatry. 1999;8:11641169.CrossRefGoogle Scholar
18.Tohen, M, Ketter, TA, Zarate, CA, et al.Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study. Am J Psychiatry. 2003;160:12631271.CrossRefGoogle ScholarPubMed
19.Sanger, TM, Tohen, M, Vieta, E, et al.Olanzapine in the acute treatment of bipolar I disorder with a history of rapid cycling. J Affect Disord. 2003;73:155161.CrossRefGoogle ScholarPubMed
20.Suppes, T, Calabrese, J, Bowden, C, et al.Lamotrigine in rapid-cycling bipolar disorder: predictors of response. W J Biol Psychiatry. 2001;3(suppl 1):S347.Google Scholar
21.Calabrese, JR, Shelton, MD, Bowden, CL, et al.Bipolar rapid cycling: focus on depression as its hallmark. J Clin Psychiatry. 2001;62(suppl 14):3441.Google ScholarPubMed
22.Suppes, T, Dennehy, EB. Evidence-based long-term treatment of bipolar II disorder. J Clin Psychiatry. 2002;63:2933.Google ScholarPubMed
23.Rush, JA, George, MS, Sackeim, JA, et al.Vagus nerve stimulation (VNS) for treatment-resistant depression: a multicenter study. Biol Psychiatry. 2000;47:276286.CrossRefGoogle ScholarPubMed
24.Sackeim, HA, Rush, JA, George, MS, et al.Vagus nerve stimulation (VNS) for treatment-resistant depression: efficacy, side effects, and predictors of outcome. Neuropsychopharmacology. 2001;5:713728.CrossRefGoogle Scholar
25.Marangell, LB, Rush, JA, George, MS, et al.Vagus nerve stimulation (VNS) for major depressive episodes: one year outcomes. Biol Psychiatry. 2002;4:280287.CrossRefGoogle Scholar